Burden of Proof for Tolvaptan in ADPKD: Did REPRISE Provide the Answer?

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1107-1109. doi: 10.2215/CJN.00190118. Epub 2018 Apr 13.
No abstract available

Keywords: ADPKD; Autosomal Dominant; Benzazepines; Biological Phenomena; Chronic; Cysts; Humans; Kidney Failure; Polycystic Kidney; Tolvaptan; United States; Urinary Tract Physiological Phenomena; chronic kidney disease; clinical trial.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antidiuretic Hormone Receptor Antagonists / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Humans
  • Multicenter Studies as Topic
  • Polycystic Kidney, Autosomal Dominant / drug therapy*
  • Tolvaptan / therapeutic use*

Substances

  • Antidiuretic Hormone Receptor Antagonists
  • Tolvaptan